Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Bloemfontein’s Visser brothers to wow hometown fans
2013-03-27

 

From left: Vincent Visser, Gareth Cliff and Vicus Visser
Photo: Supplied
27 March 2013

South Africa’s YouTube singing sensation, Vicus Visser, will wow Bloemfonteiners on 18 April 2013 with a musical performance at the University of the Free State.

He and his talented brother Vincent will perform at the Wynand Mouton Theatre giving their hometown fans a taste of their recent performances in the United States. Vicus, who has been dubbed Bloemfontein’s Justin Bieber, performed overseas for the first time in February this year when he and his brother performed at events for Black History Month in Washington DC and New York. One of their performances was at the Kennedy Centre in Washington DC where they paid tribute to Nelson Mandela and Martin Luther King.

Vicus rose to fame in 2010 when a music clip of him as a ten year old boy, singing “These Arms” by All for One, appeared on the internet. After a massive seven-year search on social media channels by local and international record companies, he was tracked down to Heidedal in Bloemfontein. Vicus and Vincent moved to Johannesburg in 2012 where they were managed and mentored by Gareth Cliff, top radio presenter and judge on Idols South Africa.

Gareth will join the Visser brothers in Bloemfontein on 18 April and will be master of ceremonies at the concert titled Singing the Dream for South Africa - The Kennedy Centre Performance. As with their performance in the United States, the brothers will treat the hometown crowd to a selection of songs in English, Zulu, Sesotho and Afrikaans.

Vicus, Vincent and Gareth will also make special appearances at the two graduation ceremonies hosted at 09:30 and 14:30 on 18 April 2013. Gareth will be guest speaker and the two brothers will give a short performance. They will also have a meet and greet session with students at the Thakaneng Bridge at 11:45.

Tickets for the Singing the Dream for South Africa - The Kennedy Centre Performance cost R 20 and are available at Room 5, Thakaneng Bridge. The show starts at 19:30.

For more information contact Nicoleen Snyman at snymann@ufs.ac.za or 051 401 9598 / 051 401 9102.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept